Nature Communications (Mar 2024)

NME3 is a gatekeeper for DRP1-dependent mitophagy in hypoxia

  • Chih-Wei Chen,
  • Chi Su,
  • Chang-Yu Huang,
  • Xuan-Rong Huang,
  • Xiaojing Cuili,
  • Tung Chao,
  • Chun-Hsiang Fan,
  • Cheng-Wei Ting,
  • Yi-Wei Tsai,
  • Kai-Chien Yang,
  • Ti-Yen Yeh,
  • Sung-Tsang Hsieh,
  • Yi-Ju Chen,
  • Yuxi Feng,
  • Tony Hunter,
  • Zee-Fen Chang

DOI
https://doi.org/10.1038/s41467-024-46385-7
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 20

Abstract

Read online

Abstract NME3 is a member of the nucleoside diphosphate kinase (NDPK) family localized on the mitochondrial outer membrane (MOM). Here, we report a role of NME3 in hypoxia-induced mitophagy dependent on its active site phosphohistidine but not the NDPK function. Mice carrying a knock-in mutation in the Nme3 gene disrupting NME3 active site histidine phosphorylation are vulnerable to ischemia/reperfusion-induced infarction and develop abnormalities in cerebellar function. Our mechanistic analysis reveals that hypoxia-induced phosphatidic acid (PA) on mitochondria is essential for mitophagy and the interaction of DRP1 with NME3. The PA binding function of MOM-localized NME3 is required for hypoxia-induced mitophagy. Further investigation demonstrates that the interaction with active NME3 prevents DRP1 susceptibility to MUL1-mediated ubiquitination, thereby allowing a sufficient amount of active DRP1 to mediate mitophagy. Furthermore, MUL1 overexpression suppresses hypoxia-induced mitophagy, which is reversed by co-expression of ubiquitin-resistant DRP1 mutant or histidine phosphorylatable NME3. Thus, the site-specific interaction with active NME3 provides DRP1 a microenvironment for stabilization to proceed the segregation process in mitophagy.